↓ Skip to main content

Efficacy and Safety of Tianeptine in Major Depression

Overview of attention for article published in CNS Drugs, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
54 Mendeley
Title
Efficacy and Safety of Tianeptine in Major Depression
Published in
CNS Drugs, August 2012
DOI 10.2165/00023210-200216010-00005
Pubmed ID
Authors

Lionel Waintraub, Lucia Septien, Paul Azoulay

Abstract

This study was performed to compare the efficacy and safety of tianeptine and paroxetine in the treatment of major depression. Anxiolytic drug use was systematically reported to provide an indirect evaluation of the anxiolytic activity of both treatments. Zopiclone use was assessed to provide an indirect evaluation of the possible hypnotic activity of both treatments.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 15%
Student > Bachelor 8 15%
Student > Master 7 13%
Other 6 11%
Student > Ph. D. Student 6 11%
Other 6 11%
Unknown 13 24%
Readers by discipline Count As %
Medicine and Dentistry 17 31%
Neuroscience 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Nursing and Health Professions 3 6%
Psychology 3 6%
Other 7 13%
Unknown 17 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2018.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from CNS Drugs
#768
of 1,388 outputs
Outputs of similar age
#64,270
of 187,955 outputs
Outputs of similar age from CNS Drugs
#275
of 541 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,388 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.6. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,955 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 541 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.